515 filings
Page 3 of 26
SC 13G/A
y6sd3e2mgslbi3h 570
4 Feb 20
GT Biopharma, Inc.
2:53pm
SC 13G/A
1xwubrzi b9x1h3
16 Jan 20
GT Biopharma, Inc.
4:30pm
EFFECT
5vb6btck75fj7gzuxo
3 Oct 19
Notice of effectiveness
12:15am
CORRESP
ouxx5yjrn899q
26 Sep 19
Correspondence with SEC
12:00am
8-K
ii27edei1bv3ie9yrjy
24 Sep 19
GT Biopharma Announces the Sale of Its Fixed Dose Combination Tablet (GTB-004) for Myasthenia Gravis (Chronic Autoimmune Disease) to Das Therapeutics
8:00am
UPLOAD
zs1u8ozkzig1
20 Sep 19
Letter from SEC
12:00am
8-K
c3213tlr
23 Aug 19
Entry into a Material Definitive Agreement
5:14pm
4
72sldy8a7
16 Aug 19
GT Biopharma / Tony Cataldo ownership change
4:57pm
4
gizuk4cj
16 Aug 19
GT Biopharma / Steven W Weldon ownership change
4:51pm
EFFECT
c8ebptdgjmn zm
15 Jul 19
Notice of effectiveness
12:15am
CORRESP
94v5hza76oi y36
8 Jul 19
Correspondence with SEC
12:00am
UPLOAD
z1nx hewqg6ijzgwj
2 Jul 19
Letter from SEC
12:00am
8-K
i5thf2bn6r 1ls9r5p90
24 May 19
Entry into a Material Definitive Agreement
6:14am
8-K
a4mmuv
19 Apr 19
Unregistered Sales of Equity Securities
4:23pm